INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Warren Remedies Private Ltd., a wholly owned subsidiary of Indoco Remedies Ltd. commences commercial production of Pharmaceutical Intermediates
Indoco Remedies purchase land parcel in Mumbai; share gains
The share touched a 52-week high of Rs 416.95 on January 1, 2024 and and a 52-week low of Rs 307 on April 26, 2023 INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Pursuant to Regulation 30 of the Securities & Exchange Board of India (LODR) Regulations, 2015 , we would like to inform that the Committee of Executive Directors at its meeting held today i.e. 12-03-2024 has approved the purchase of land from an unrelated third party seller "Saldanha Realty & Infrastructure LLP." INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Warren Remedies Private Ltd, a wholly owned subsidiary of Indoco Remedies Limited commences commercial production of Oral Care Products. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Corporate Guarantee For Warren Remedies Private Limited, Wholly Owned Subsidiary Of The Company
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we would like to inform you that the Committee of Executive Directors at its meeting held on 30-01-2024 approved the Corporate Guarantee upto a maximum principal amount of Rs. 125 crores in favour of HDFC bank Ltd in respect of the Loan /credit facilities to be availed in tranches by Warren Remedies Pvt Ltd, wholly owned subsidiary of the Company. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of SEBI(LODR) Regulations, please find enclosed the transcript of Earnings Conference Call held on 23rd January, 2024 at 03:30 p.m.
Indoco Remedies Q3 FY24 Results Live : profit falls by 42.08% YOY
Indoco Remedies Q3 FY24 Results Live : Revenue increased by 15.09% YoY & profit decreased by 42.08% YoY INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31-12-2023